期刊
MOLECULAR AND CELLULAR BIOLOGY
卷 23, 期 1, 页码 14-25出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.23.1.14-25.2003
关键词
-
资金
- NCI NIH HHS [CA47159, CA25874, R01 CA047159, P01 CA025874, P30 CA010815, CA10815] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [P30CA010815, R01CA047159, P01CA025874] Funding Source: NIH RePORTER
Notch and its ligands play critical roles in cell fate determination. Expression of Notch and ligand in vascular endothelium and defects in vascular phenotypes of targeted mutants in the Notch pathway have suggested a critical role for Notch signaling in vasculogenesis and angiogenesis. However, the angiogenic signaling that controls Notch and ligand gene expression is unknown. We show here that vascular endothelial growth factor (VEGF) but not basic fibroblast growth factor can induce gene expression of Notch1 and its ligand, Delta-like 4 (DII4), in human arterial endothelial cells. The VEGF-induced specific signaling is mediated through VEGF receptors I and 2 and is transmitted via the phosphatidylinositol 3-kinase/Akt pathway but is independent of mitogen-activated protein kinase and Src tyrosine kinase. Constitutive activation of Notch signaling stabilizes network formation of endothelial cells on Matrigel and enhances formation of vessel-like structures in a three-dimensional angiogenesis model, whereas blocking Notch signaling can partially inhibit network formation. This study provides the first evidence for regulation of Notch/Delta gene expression by an angiogenic growth factor and insight into the critical role of Notch signaling in arteriogenesis and angiogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据